About CARI Guidelines


CARI Guidelines mission is to improve the quality of care and outcomes for patients with kidney disease in Australia & New Zealand by facilitating the development and implementation of trustworthy clinical practice guidelines based on the best available evidence

CARI Guidelines Governance

CARI Guidelines operates as an externally funded research program within the School of Public Health, Faculty of Health and Medicine at the University of Sydney. CARI Guidelines day-to-day operations are overseen by a Scientific Director, who reports to the Head of School at the School of Public Health, The University of Sydney. CARI Guidelines Steering Committee provides oversight regarding strategic direction and priority-setting.

Why have guidelines?

Clinical practice guidelines have proved enormously valuable, and adherence to the recommendations translates directly into benefits for patients through improved outcomes, benefits for practitioners through better quality of care, and benefits for providers through improved cost-effectiveness. Guidelines are considered to reduce the use of unnecessary, ineffective, or harmful interventions and to facilitate the treatment of patients with:

  • maximum chance of benefit
  • minimum risk of harm
  • and at an acceptable cost

Who we are

CARI Guidelines is overseen by Steering Committee of consumers, nephrologists, and allied health professionals. The members serve as an advisory body and provide a strategic direction for CARI Guidelines.

Rathika Krishnasamy, University of Queensland, Brisbane, QLD (Chair)
Jane Boag, Consumer partner
Helen Coolican, PKD Australia, Consumer partner
Vanessa Cullen, Consumer partner
Jonathan Craig, Flinders University, Adelaide, SA
Debbie Fortnum, Sir Charles Gairdner Hospital & University of Western Australia, Perth, WA.
Min Jun, The George Institute of Global Health, The University of New South Wales, Sydney, NSW.
Kelly Lambert, University of Wollongong, Wollongong, NSW
Vincent Lee, Westmead Hospital, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW
Carla Scuderi, Royal Brisbane and Women's Hospital, The University of Queensland, Brisbane, QLD
Emily See, University of Melbourne, Melbourne, VIC
Andrea Viecelli, University of Queensland, Brisbane, QLD
Rachael Walker, Eastern Institute of Technology, Hawke’s Bay, New Zealand

CARI Guidelines is supported by over a 100 guideline writers, who are selected for their interest and expertise in the clinical area covered by the Guideline Working Groups.

CARI Guidelines is supported by a group of dedicated staff that support guideline writers in the development of guidelines. Staff have expertise in consumer involvement in research and guidelines, evidence synthesis, including the use of GRADE, copy-editing, and training.

David Tunnicliffe (Scientific Director)
Brydee Cashmore
Jonathan Craig
Chandana Guha
Martin Howell
Andrea Matus-Gonzalez
Nicki Scholes-Robertson
Allison Tong
Adela Yip

Guideline development process

More than 100 guideline writers have been involved in researching and writing CARI guidelines. Guideline writers are invited to attend a one-day methods workshop run by the CARI office to help equip them for the task of scanning the literature and writing clinical practice guidelines. This training teaches participants how to critically review and summarise the relevant literature on their topic, how to grade the quality of studies and integrate them into their guidelines, and in general, improves their critical appraisal skills.

The CARI office staff assists writers by conducting systematic literature searches, locating relevant trials, and preparing summary evidence tables for each guideline subtopic.

The procedures and methodology used for guideline development and adaptation can be found below.

Guideline Development Handbook